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The large delta antigen (LDAg) of hepatitis D virus (HDV), which is similar to the small delta antigen (SDAg), except it
has 19 additional amino acids and an isoprenylation signal at the C-terminus, is crucial for interacting with hepatitis B
surface antigen (HBsAg) to form a mature virion of HDV. Previous studies indicated that the LDAg alone, but not SDAg,
can interact with HBsAg to form an empty particle. However, no evidence yet shows whether the intermolecular interaction
of LDAg is necessary for forming an empty HDV particle. By cotransfection of plasmids encoding deletion or isoprenylation-
negative mutants of LDAg with a plasmid encoding HBsAg into human hepatoma cells, we demonstrated that (i) the
isoprenylation-negative LDAg cannot be secreted, (ii) the coiled-coil domain-deleted LDAg retains the secretion capability,
(iii) the isoprenylation-negative LDAg can neither cosecrete with isoprenylation-positive LDAg nor suppress its secretion,
and (iv) an intermolecular interaction between LDAgs is unlikely required for secretion. A hypothetical model of empty
HDV particle containing HBsAg with isoprenylated LDAgs, which are probably present in a singular form, was then
proposed. q 1996 Academic Press, Inc.
Hepatitis D virus (HDV) is a defective RNA virus and Several lines of evidence indicate that interaction be-
tween two isoforms of DAg is crucial for HDV replication,requires hepatitis B virus (HBV) supplying envelope pro-
teins for completion of package, secretion, and infection assembly, and secretion (17–20). The coiled-coil motif
at the first leucine zipper of DAg is required for a complex(1–3). However, no HBV product is needed for HDV ge-
nome replication observed in HDV cDNA-transfected formation to exert SDAg’s activation or LDAg’s inhibition
function (21). The SDAg alone cannot be packaged andmammalian cell systems (4, 5). During HDV replication,
two different sizes of antigen, termed small and large secreted with HBsAg. However, such deficiency is con-
ferred by the presence of LDAg, indicating a direct inter-delta antigen (SDAg and LDAg, respectively), are synthe-
sized. The SDAg is an essential factor for HDV RNA action between LDAg and SDAg occurs inside of HBsAg-
containing particles (7, 22, 23). There is not any informa-replication, while the LDAg acts as a dominant negative
tion that an intermolecular interaction between LDAgsrepressor (4, 6). Moreover, the LDAg is crucially required
is required for its roles of assembly and secretion. Wefor interaction with HBV surface antigen (HBsAg) for se-
therefore designed a deletion and isoprenylation-nega-cretion (7). These two isoforms share an identical se-
tive mutants to examine whether a direct interaction ofquence of 195 amino acids except that the LDAg has an
LDAg is necessary for its secretion with HBsAg.excess 19 amino acids at the C-terminus (8, 9). Within
Four plasmids encoding various forms of LDAg, desig-the common 195-amino-acid sequence of SDAg and
nated as pMTLD, pMTLDm, pMTLDD(35–75), andLDAg, two leucine zipper-like motifs (30 to 51 aa and 108
pMTLDD(35–75)m, respectively, were constructed into 130 aa, respectively), RNA binding motif, and nuclear
this study. Expression of LDAg from these plasmids waslocalization signal are identified (10–13). In addition, an
driven by the human metallothionine promoter. Theisoprenylation signal is identified within the C-terminal
pMTLD plasmid encodes a wild type of LDAg (desig-19 amino acids of LDAg (14, 15). This isoprenylation sig-
nated as LD-W herein), whereas the pMTLDm encodesnal and its upstream of 15 amino acids are required for
a serine-substituted mutant (at the 211th amino acid) ofLDAg interaction with HBsAg to form a secretable empty
LDAg (designated as LD-M herein) which abolished theHDV particle (15, 16).
isoprenylation signal (14, 15). The pMTLDD(35–75) con-
struct was derived from pMTLD by deletion of the BspEI1 Present address: Institute of Biomedical Sciences, Academia Si-
fragment (120 bp) resulting in loss of 35–75 amino acidsnica, Taipei, Taiwan.
of LDAg (designated as LD-dc). Similarly, deletion of the2 To whom correspondence and reprint requests should be ad-
dressed. Fax: 886-2-8212880. E-mail: losj@ym.edu.tw. BspEI fragment of pMTLDm resulted in pMTLDD(35–
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Since the full-length and deleted LDAg could be easily
distinguished by a Western blot, combination of various
plasmids in transfection was used to elucidate whether
the other domains of LDAg are required for a direct asso-
ciation in secretion. We performed three plasmids (two
plasmids encoding various lengths of LDAg and one en-
coding HBsAg) cotransfection and Western blot analysis.
Figure 2A shows the isoprenylation-negative mutants
(LD-M and LD-dcM, respectively) could not be cose-
creted by the deleted or wild-type LDAg (LD-dc and LD-
W, respectively) (lanes 1 and 2). However, both LD-W
and LD-dc remaining the isoprenylation signal were co-FIG. 1. Western blot analysis of various forms of LDAg present intra-
secreted (lane 3). No cosecretion of isoprenylation-nega-cellularly (lanes 1 and 2) and extracellularly (lanes 3–6). Lanes 1 and
3 are from the pMTLD transfection; lanes 2 and 4 from pMTLDm; tive mutants with wild-type or deleted LDAg suggested
lane 5 from pMTLDD(35–75); lane 6 from pMTLDD(35–75)m. M lanes that no direct interaction between LDAg molecules is
represent prestained protein size markers with molecular mass indi- required for secretion.cated at the left side.
To further investigate whether isoprenylation-negative
mutants could interact with secretable LDAgs intracellu-
larly and retard their secretion, experiments of three-75)m, which encodes a doubly mutated protein desig-
nated as LD-dcM.
The four plasmids were individually cotransfected with
pMTS which encodes a major surface antigen of HBV
(HBsAg) (24) into a human hepatoma cell, HuH-7 (25),
by a calcium-phosphate precipitation method (26). Fresh
media were then changed every 3 days after post-
transfection. The media of Day 6 and Day 9 were pooled
together and viral particles were concentrated by ultra-
centrifugation. The secretion of LDAg with HBsAg was
analyzed by a Western blotting method (27). The Day 9
posttransfected cells were scraped off from the plates
and dispersed by lysis buffer, which were then examined
for the expression of LDAg by anti-DAg antibody immuno-
precipitation followed by Western blot analysis (27).
Western blot results indicated that both wild type LDAg
(LD-W) and isoprenylation-negative mutant (LD-M) were
produced inside of transfected cells (Fig. 1, lanes 1 and
2). The amount of LD-W was constantly less than that of
LD-M. However, the LD-W was secreted with HBsAg,
whereas the LD-M was not detected extracellularly
(lanes 3 and 4). This observation is consistent with the
previous reports (14, 15). The higher amount of LD-M
observed inside of cells could simply be due to the accu-
mulation of the nonsecretable species. Similarly, both
deletion mutant (LD-dc) and doubly mutated protein (LD-
dcM) were synthesized inside of transfected cells (data
not shown). The LD-dc protein retained the secretion
capability while the double mutant (LD-dcM) was not
secreted (lanes 5 and 6). These results further supported
FIG. 2. Western blot analysis of secreted LDAgs by cotransfection of
that the isoprenylation signal of LDAg is required for plasmid encoding HBsAg and two different plasmids encoding various
secretion and indicated that the coiled-coil domain lo- forms of LDAg, which were in either equal amount (A) or various ratio
(B). (A) Lane 1 is from transfection of pMTLDm and pMTLDD(35–75);cated at 35–75 aa is dispensable for secretion (21, 23)
lane 2 is from pMTLD and pMTLDD(35–75)m; and lane 3 is fromalthough that domain is required for trans-suppression
pMTLD and pMTLDD(35–75). (B) Lanes 1–3 are from pMTLD andactivity of LDAg (21). The data also suggested if an inter-
pMTLDD(35–75) in a ratio of 1:10, 1:1, and 10:1, respectively, while
molecular interaction of LDAgs is required for secretion lanes 4–6 are from pMTLDm and pMTLDD(35–75) as a ratio of the
the interaction domain should be a region other than 35 – former group. M indicates protein size markers with molecular mass
shown at the left side of the panel.75 aa residues of LDAg.
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is no prenylation-free LDAg (LD-M or LD-dcM) inside of
empty HDV particle as demonstrated in this study.
The finding of no prenylation-free LDAg present in an
empty HDV particle raises questions: (i) what is the ac-
tual pathway of LDAg in the HDV mature virion assembly
and (ii) whether mature and empty HDV particles are
formed simultaneously in HDV-infected patients. There
are two possible hypotheses. First, it could be that the
LDAg enters the nucleus and forms an RNP (ribonucleo-
protein) complex with SDAg and virion RNA genome (32);
after translocating into the cytoplasm and the LDAg being
isoprenylated, the complex attaches on ER membrane
FIG. 3. A hypothetical model of HDV empty particle. HBsAg (solid and finally interacts with HBsAg to form a mature HDV
oval shape) in a monomer, dimer, or multimer form is dispersed in a
particle. In this case, the LDAg forming an RNP complexphospholipid bilayer (two lines), while LDAg (diamond shape) linking
is a prerequisite for isoprenylation modification and noby an isoprenoid derivative (bar) on the inner side of the bilayer is
singularly associated with HBsAg. empty HDV particle will be produced. Alternatively, the
LDAg could target two destinations simultaneously; one
is isoprenylated and attaches on ER membrane and the
plasmid cot ra nsf e ct i on i n a var io u s rat io of other enters the nucleus and forms an RNP particle. After
pMTLD:pMTLDD(35–75) and pMTLDm:pMTLDD(35 – the RNP translocates into the cytoplasm and interacts
75) plus a constant amount of pMTS (24) were con- with the ER-bound LDAg and HBsAg, it becomes a ma-
ducted. Western blot analysis indicated that LD-M could ture virion. In this case, the isoprenylated LDAg has
neither be cosecreted with LD-dc nor suppress LD-dc changed its conformation and is allowed to bind with
secretion in 1/10, equal, or 10-fold amount of LD-dc (Fig. SDAg, HDV genomic RNA, or RNP complex to form
2B, lanes 4–6), indicating that a direct interaction did not empty, defective, or mature virions. Although our current
occur between two forms of LDAg (LD-M and LD-dc) in study favors the latter hypothesis, analyses of the ratio
secretion, and LD-M could not be a dominant negative of prenylated:nonprenylated LDAg from nucleus, cyto-
suppressor for secretion. However, LD-W and LD-dc plasm, and ER fractions and HDV virion will probably
were detected proportionally to the amount of plasmids give the answer.
transfected (lanes 1–3), suggesting that they were se-
creted independently, regardless if in the same or differ- ACKNOWLEDGMENTS
ent particles.
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